Showing results (1761-1770 of 2,138) with videos related to

Sort By:
Pageof 214
Journal of Vitreoretinal Diseases|May 1, 2026
A Single-Center Analysis of Variables Used to Select a Vitreoretinal Surgery Training ProgramTimothy M Boyce, Kyle M Green, Ian C Han, et al.
DNA and Cell Biology|January 1, 1997
Human uteroglobin gene: structure, subchromosomal localization, and polymorphismZ Zhang, D B Zimonjic, N C Popescu, et al.
Blood|August 14, 2010
Arsenic trioxide improves event-free and overall survival for adults with acute promyelocytic leukemia: North American Leukemia Intergroup Study C9710Bayard L Powell, Barry Moser, Wendy Stock, et al.
Bone|October 22, 2013
Denosumab compared with risedronate in postmenopausal women suboptimally adherent to alendronate therapy: efficacy and safety results from a randomized open-label studyC Roux, L C Hofbauer, P R Ho, et al.
Investigative Ophthalmology & Visual Science|January 27, 2005
Disease expression in Usher syndrome caused by VLGR1 gene mutation (USH2C) and comparison with USH2A phenotypeSharon B Schwartz, Tomas S Aleman, Artur V Cideciyan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 18, 2001
United States multicenter study of arsenic trioxide in relapsed acute promyelocytic leukemiaS L Soignet, S R Frankel, D Douer, et al.
Stem Cells Translational Medicine|May 6, 2017
Connective Tissue Growth Factor Promotes Efficient Generation of Human Induced Pluripotent Stem Cell-Derived Choroidal EndotheliumAllison E Songstad, Kristan S Worthington, Kathleen R Chirco, et al.
JAMA|June 11, 2009
Allogeneic stem cell transplantation for acute myeloid leukemia in first complete remission: systematic review and meta-analysis of prospective clinical trialsJohn Koreth, Richard Schlenk, Kenneth J Kopecky, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|October 4, 2018
Correction: Prefrontal GABA levels, hippocampal resting perfusion and the risk of psychosisGemma Modinos, Fatma Şimşek, Matilda Azis, et al.
Psychopharmacology|August 15, 2025
The GPR139 agonist TAK-041 produces time-dependent alterations to cerebral blood flow and reward system function in patients with schizophrenia: a randomised placebo-controlled trialPeter C T Hawkins, Adam J Schwarz, James M Stone, et al.
Pageof 214